Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,278 | 291 | 55.1% |
| Consulting Fee | $4,000 | 1 | 35.1% |
| Travel and Lodging | $851.97 | 6 | 7.5% |
| Education | $253.97 | 4 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,750 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $866.19 | 51 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $520.52 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $461.98 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $422.50 | 22 | $0 (2024) |
| Lilly USA, LLC | $336.62 | 15 | $0 (2024) |
| Galderma Laboratories, L.P. | $306.86 | 13 | $0 (2023) |
| PFIZER INC. | $259.34 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $172.61 | 8 | $0 (2024) |
| Allergan Inc. | $149.14 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,258 | 53 | E.R. Squibb & Sons, L.L.C. ($252.93) |
| 2023 | $1,045 | 48 | ABBVIE INC. ($251.07) |
| 2022 | $601.14 | 27 | ABBVIE INC. ($247.67) |
| 2021 | $295.14 | 13 | Janssen Biotech, Inc. ($130.61) |
| 2020 | $210.55 | 11 | Novartis Pharmaceuticals Corporation ($92.15) |
| 2019 | $1,159 | 52 | AbbVie, Inc. ($214.70) |
| 2018 | $6,055 | 59 | AbbVie, Inc. ($5,578) |
| 2017 | $759.19 | 39 | Novartis Pharmaceuticals Corporation ($192.87) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $86.98 | General |
| 11/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $3.59 | General |
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.98 | General |
| 10/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $112.01 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $106.62 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DERMATOLOGY | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.79 | General |
| Category: Immunology | ||||||
| 08/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DERMATOLOGY | ||||||
| 08/14/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 08/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: Immunology | ||||||
| 07/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $37.06 | General |
| Category: Dermatology | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,603 | 6,966 | $1.5M | $275,628 |
| 2022 | 21 | 3,532 | 6,582 | $705,975 | $275,323 |
| 2021 | 19 | 3,233 | 6,099 | $661,461 | $268,236 |
| 2020 | 16 | 3,016 | 6,214 | $640,489 | $232,922 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 945 | 1,216 | $386,688 | $71,096 | 18.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 421 | 487 | $204,540 | $40,475 | 19.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 627 | 782 | $191,590 | $30,193 | 15.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 148 | 205 | $126,485 | $26,452 | 20.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 288 | 336 | $127,680 | $22,190 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 245 | $109,270 | $21,257 | 19.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 502 | 3,085 | $77,125 | $16,612 | 21.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 49 | 53 | $58,989 | $12,332 | 20.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 52 | 77 | $37,576 | $7,571 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 118 | 118 | $46,374 | $7,526 | 16.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 41 | 48 | $42,768 | $4,921 | 11.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 67 | 107 | $20,223 | $4,482 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $18,624 | $3,558 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 68 | $13,668 | $2,895 | 21.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 21 | $13,671 | $2,574 | 18.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 25 | $5,175 | $764.37 | 14.8% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 14 | $4,970 | $697.12 | 14.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 47 | $188.00 | $30.71 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 826 | 1,040 | $121,680 | $60,594 | 49.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 398 | 481 | $91,871 | $39,673 | 43.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 192 | 258 | $87,978 | $32,321 | 36.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 309 | 369 | $67,162 | $25,578 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 555 | 688 | $92,880 | $25,227 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 267 | $47,526 | $22,805 | 48.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 448 | 2,666 | $50,654 | $14,353 | 28.3% |
About Tiffany Link, M.D., PH.D
Tiffany Link, M.D., PH.D is a Dermatology healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1851683106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tiffany Link, M.D., PH.D has received a total of $11,384 in payments from pharmaceutical and medical device companies, with $1,258 received in 2024. These payments were reported across 302 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,278).
As a Medicare-enrolled provider, Link has provided services to 13,384 Medicare beneficiaries, totaling 25,861 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Fort Collins, CO
- Active Since 05/04/2011
- Last Updated 01/05/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1851683106
Products in Payments
- Humira (Biological) $580.53
- COSENTYX (Biological) $516.85
- SKYRIZI (Biological) $448.67
- Sotyktu (Drug) $437.42
- DUPIXENT (Biological) $297.32
- RINVOQ (Biological) $266.68
- TALTZ (Drug) $249.64
- ILUMYA (Biological) $237.18
- EUCRISA (Drug) $228.72
- EPIDUO FORTE (Drug) $213.09
- TREMFYA (Drug) $156.55
- Tremfya (Drug) $149.45
- COSENTYX (Drug) $129.06
- STELARA (Biological) $125.01
- BOTOX COSMETIC (Biological) $123.49
- REMICADE (Biological) $92.97
- Winlevi (Drug) $87.18
- ADBRY (Biological) $86.56
- HUMIRA (Biological) $78.26
- BLU-U (Medical Supply) $66.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Collins
Dr. Anne-Lise Hultsch, M.d, M.D
Dermatology — Payments: $8,418
Emily Stevens, M.d, M.D
Dermatology — Payments: $6,318
Joseph Wilde, M.d, M.D
Dermatology — Payments: $5,065
Dr. Brooke Caufield, Md, MD
Dermatology — Payments: $2,441
Dr. Barbara West, M.d, M.D
Dermatology — Payments: $1,606
Dr. Joseph Lillis, M.d, M.D
Dermatology — Payments: $1,108